ProfileGDS4718 / 220725_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 65% 63% 67% 68% 66% 66% 64% 64% 68% 68% 67% 63% 63% 66% 64% 67% 63% 67% 71% 59% 65% 66% 65% 66% 63% 67% 66% 71% 66% 65% 65% 65% 68% 61% 63% 68% 61% 65% 64% 68% 69% 63% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6586767
GSM549102patient 115, normal, homogenized [OPG study]6.4701165
GSM549104patient 119, normal, homogenized [OPG study]6.3331363
GSM549108patient 138, normal, homogenized [OPG study]6.6364167
GSM549119patient 077, normal, homogenized [OPG study]6.661668
GSM549133patient 032, cancer, homogenized [OPG study]6.5315866
GSM549139patient 042, cancer, homogenized [OPG study]6.5748866
GSM549099patient 107, normal, homogenized [OPG study]6.4019264
GSM549109patient 139, normal, homogenized [OPG study]6.4386164
GSM549110patient 046, normal, homogenized [OPG study]6.7052868
GSM549114patient 063, normal, homogenized [OPG study]6.6618268
GSM549122patient 082, normal, homogenized [OPG study]6.6197467
GSM549134patient 033, cancer, homogenized [OPG study]6.3420263
GSM549136patient 036, cancer, homogenized [OPG study]6.3418863
GSM549140patient 044, cancer, homogenized [OPG study]6.5636466
GSM549111patient 047, normal, homogenized [OPG study]6.4340464
GSM549113patient 057, normal, homogenized [OPG study]6.6198167
GSM549132patient 031, cancer, homogenized [OPG study]6.3118663
GSM549137patient 038, cancer, homogenized [OPG study]6.6600967
GSM549142patient 047, cancer, homogenized [OPG study]6.9261171
GSM549100patient 110, normal, homogenized [OPG study]6.074359
GSM549107patient 135, normal, homogenized [OPG study]6.4885665
GSM549115patient 068, normal, homogenized [OPG study]6.5536866
GSM549116patient 072, normal, homogenized [OPG study]6.5098265
GSM549120patient 078, normal, homogenized [OPG study]6.5713766
GSM549131patient 030, cancer, homogenized [OPG study]6.292963
GSM549118patient 074, normal, homogenized [OPG study]6.6259767
GSM549129patient 027, cancer, homogenized [OPG study]6.6294966
GSM549123patient 088, normal, homogenized [OPG study]7.0070571
GSM549124patient 006, cancer, homogenized [OPG study]6.5403866
GSM549126patient 015, cancer, homogenized [OPG study]6.447465
GSM549128patient 025, cancer, homogenized [OPG study]6.5303265
GSM549103patient 117, normal, homogenized [OPG study]6.4516165
GSM549117patient 073, normal, homogenized [OPG study]6.6777968
GSM549138patient 041, cancer, homogenized [OPG study]6.2290861
GSM549141patient 045, cancer, homogenized [OPG study]6.3372363
GSM549130patient 028, cancer, homogenized [OPG study]6.7140468
GSM549101patient 111, normal, homogenized [OPG study]6.2447361
GSM549105patient 128, normal, homogenized [OPG study]6.466865
GSM549106patient 134, normal, homogenized [OPG study]6.4329164
GSM549112patient 048, normal, homogenized [OPG study]6.7166668
GSM549125patient 011, cancer, homogenized [OPG study]6.7496169
GSM549127patient 024, cancer, homogenized [OPG study]6.3976663
GSM549135patient 035, cancer, homogenized [OPG study]6.3702863